Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignances

Christopher W. Ryan, Nicholas J. Vogelzang, Everett E. Vokes, Hedy L. Kindler, Samir D. Undevia, Rod Humerickhouse, Amy K. André, Qiang Wang, Robert A. Carr, Mark J. Ratain

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignances'. Together they form a unique fingerprint.

Medicine & Life Sciences